Tinnitus and Hyperacusis (TH)
Instructional Level: Intermediate
Tinnitus affects ~10-15% of the population. Unfortunately, there are limited treatment options. A new non-invasive neuromodulation device using auditory and trigeminal nerve stimulation has been evaluated in more than 500 tinnitus patients across two randomized clinical trials. Using widely accepted outcome measures, this device significantly improved tinnitus symptoms within a short period of treatment (6 weeks, ~30-60 minutes per day), which was reproducible across studies. Specific stimulation patterns also provided sustained improvements for at least 12 months after treatment cessation.